“akcea-therapeutics” Archives

in
Entry Author Date Location
Akcea, Fresh Off C-Suite Shakeup, Dishes Heart Drug to Pfizer for $250M 10/07/19 Boston
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More 09/27/19 National
Akcea Shakes Up Management and Shows Three Executives the Door 09/23/19 Boston
Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More 05/10/19 National
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea 05/06/19 New York
Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More 04/19/19 National
Bio Roundup: Pharma in DC, Bristol-Cel in Trouble, Roche Gets A Spark 03/01/19 National
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More 10/12/18 National
FDA OKs Akcea Rare Disease Drug, Setting Up Market Clash with Alnylam 10/05/18 Boston
Akcea to Cut Staff 10% in Wake of FDA Rejection of Rare Disease Drug 09/06/18 Boston
Bio Roundup: Pfizer’s Rare Results, U.K.’s CAR-T No, IPO Go-Go & More 08/31/18 National
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug 08/30/18 Boston
FDA Gives Thumbs-Down to Rare Disease Drug from Ionis, Akcea 08/27/18 San Diego
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug 08/10/18 Boston
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision 08/03/18 Boston
Bio Roundup: Pfizer’s Prices, Novartis Cuts, Gene Therapy Guide & More 07/13/18 National
EU Regulators Approve Akcea’s Inotersen. FDA Decisions Are Next. 07/11/18 Boston
Down the Stretch: Akcea, Alnylam Face Reality Checks as FDA Dates Loom 07/06/18 Boston
Bio Roundup: Dunsire’s Danish, Price Hikes, Rare-Disease Race & More 07/06/18 National
Bio IPO Madness: Six Biotech Startups Raise $568M in 24 Hours 06/21/18 National
Bio Roundup: Moderna’s Billions, Cytokine Bets, Shire Acquired & More 05/11/18 National
Bio Roundup: DIY Biohacking, PCSK9 Data, Solid Setback & More 03/16/18 National
Bio Roundup: Funding Frenzy, Opioid Summit, Celgene Woes & More 03/02/18 National
Spero, Allena Nab $152M As Bio IPOs, With Insider Help, Continue Roll 11/02/17 Boston
Rhythm Pharma IPO Pops to the Tune of a $120M Upsized Offering 10/05/17 Boston
Bio Roundup: CAR-T’s Huge Week, Merck’s ‘Pib Choice & More 09/01/17 National
GSK Hands Nerve Drug Back to Ionis as RNA Battle Heats Up 08/11/17 San Diego
Bio Roundup: Obamacare Persists, FDA Approves, Vertex Wows & More 07/21/17 National
Akcea Slashes IPO Price Ahead of Filing for Rare Disease Drug 07/14/17 Boston
Bio Roundup: New Drug Bonanza, Vertex’s Triple Play, CAR-T Race & More 03/31/17 National
Page 1 of 2 next page »